US Patent Issued to Biscayne Neurotherapeutics on Dec. 23 for "Use of higher doses of modified release huperzine formulations" (Florida, Illinois, North Carolina Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,356, issued on Dec. 23, was assigned to Biscayne Neurotherapeutics Inc. (Rockville, Md.).

"Use of higher doses of modified release huperzine formulations" was invented by Stephen D. Collins (Lake Forest, Ill.), Peter J. Goldstein (Hollywood, Fla.) and Joshua T. Johnstone (Apex, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application discloses pharmaceutical compositions and methods of treating neurological disorders and seizure disorders with the high dose modified release compositions of huperzine. The pharmaceutical compositions and methods described herein, allow for higher dosing of huperzine, while avoiding rapid peak plasma...